A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
type: MedicalStudy
description: A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM
status: ACTIVE_NOT_RECRUITING
study design: INTERVENTIONAL
phase: PHASE2
start date: 2024-11-07
end date: 2026-11-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06660173
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Amgen
study subject: Type 2 Diabetes Mellitus (T2DM)
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: ACTIVE_NOT_RECRUITING
keywords: Type 2 Diabetes Mellitus (T2DM)

AI Analytics
type: Organization